ALL ABOUT GAFFI

Fungal diseases are neglected worldwide by public health authorities.

GAFFI efforts are directed at:

Identifying and publicising gaps in diagnostics and treatments for fungal diseases.
Consulting on how services could be improved through facilitating training, encouraging companies to expand their markets and recommending improvements in infrastructure.
Estimating the burden of serious fungal diseases, country by country. Over 65 countries with a population >1 million have been addressed, and many are published.
Develop, implement and evaluate country-wide diagnostic programs. Guatemala (fungal infections in AIDS) is the first.
Influence national and international agencies to ‘adopt’ fungal diseases alongside existing programs including TB, microbiology, AMR, NTDs and incorporation of key generic antifungals onto the WHO Essential Medicines List.
Focussed diagnostic improvements for GAFFI’s priority diseases.

06/08/19

Hyper-endemic areas for histoplasmosis revealed in new SE Asian maps

11/07/19

Following GAFFI submission WHO endorses Histoplasma antigen as an Essential Diagnostic

05/07/19

LDBio rapid Aspergillus IgG test is sensitive and specific for chronic pulmonary aspergillosis

By 2025, our goal is to ensure that 95% of people with serious fungal disease are diagnosed and 95% treated.

Download our roadmap PDF

HOW 150 PEOPLE DIE EVERY HOUR FROM FUNGAL INFECTION WHILE THE WORLD TURNS A BLIND EYE

Gaffi is the only global NGO focussed exclusively on fungal diseases.

Our vision is to reduce illness and death associated with fungal diseases worldwide.

Our mission is to reach the poor and vulnerable through access to tests and anti fungal drugs.

Download our brochure

GAFFI’s Chief Executive David Denning summarises GAFFI’s achievements over the last 6 years.

Meet the people who together are the driving force behind GAFFI and are the true leaders behind making a difference to thousands of people’s lives.